Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists показать больше
comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy University of Texas Medical Branch to treat impulse control disorders, such as binge eating and Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.
Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy University of Texas Medical Branch to treat impulse control disorders, such as binge eating and Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.
– моментальные уведомления о рынке акций
